Truist lowered the firm’s price target on Westlake (WLK) to $90 from $94 and keeps a Buy rating on the shares. The firm is citing its more muted earnings expectations for both the Performance & Essential Materials, PEM, and Housing & Infrastructure Products, HIP, segments, the analyst tells investors in a research note. Truist adds that the assumed EBITDA multiple is supported by the company’s integration into HIP, which provides earnings stability and margin accretion relative to the PEM commodity chemicals business.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK:
- Westlake price target lowered to $90 from $92 at Mizuho
- Westlake price target lowered to $93 from $100 at Citi
- Westlake Corporation: Hold Rating Amid Revised Earnings, Market Challenges, and Inflationary Pressures
- JPMorgan healthcare analysts hold an analyst/industry conference call
- Westlake price target raised to $78 from $73 at JPMorgan